Videos Steve Reitmeister shares details from a recent Zacks Rank performance study to help investors set realistic expectations. Articles You May Like Dental supply stock surges on RFK’s anti-fluoride stance, activist involvement Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook Activist ValueAct is poised to trim fat and help boost profits at Meta Platforms. Here’s how Quantum Computing: The Key to Unlocking AI’s Full Potential? Autonomous Vehicles: Why 2025 Will Usher in the Self-Driving Car